0

Anthralin (Dithranol)

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP1143380-B
CAS1143-38-0
Structure
MDL NumberMFCD00053409
Molecular Weight226.23
EC Number214-538-0
InChI KeyNUZWLKWWNNJHPT-UHFFFAOYSA-N
REAXYS Number2054360
DescriptionPharmaceutical Secondary Standard; Certified Reference Material
Gradecertified reference material; pharmaceutical secondary standard
MP178-181 °C (lit.); traceable to USP 1039006
Size1G
1

Alteration of the Expression of Bcl-2, Bcl-x, Bax, Fas, and Fas Ligand in the Involved Skin of Psoriasis Vulgaris Following Topical Anthralin Therapy

T Yamamoto, K Nishioka

Skin Pharmacol Appl Skin Physiol. Jan-Feb 2003;16(1):50-8.

PMID: 12566829

1

Anthralin (Dithranol) in Vitro Inhibits Human Monocytes to Secrete IL-6, IL-8 and TNF-alpha, but Not IL-1

U Mrowietz, H Jessat, A Schwarz, T Schwarz

Br J Dermatol. 1997 Apr;136(4):542-7.

PMID: 9155955

1

Anthralin Modulates the Expression Pattern of Cytokeratins and Antimicrobial Peptides by Psoriatic Keratinocytes

Julia Holstein, Birgit Fehrenbacher, Jürgen Brück, Eva Müller-Hermelink, Iris Schäfer, Melanie Carevic, Birgit Schittek, Martin Schaller, Kamran Ghoreschi, Franziska C Eberle

J Dermatol Sci. 2017 Sep;87(3):236-245.

PMID: 28673488

1

Anthralin/dithranol in Dermatology

Virendra N Sehgal, Prashant Verma, Ananta Khurana

Int J Dermatol. 2014 Oct;53(10):e449-60.

PMID: 25208745

1

The Effect of Anthralin (Dithranol) on Mitochondria

P Morlière, L Dubertret, T Sa e Melo, C Salet, M Fosse, R Santus

Br J Dermatol. 1985 May;112(5):509-15.

PMID: 4005152

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode